REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/26/2025
Back to search
Official data from USPTO
EQUITAS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
EQUITAS
ST13
US500000086848934Class
35, 42, 45
Filing
86848934
Registration
5007758
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
07/27/2025
Classification
Registered
Trademark type
Word
Nice classes
35, 42, 45
Filing date
12/14/2015
Registration date
07/26/2016
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/25/2022
Last transaction
07/27/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
04/16/2015
First use in commerce
04/22/2015
Drawing code
4
Owner type
16
Owner location
NYACK, NY
Examiner
WIENER, MICHAEL
Law office
L80
Current location
TMEG LAW OFFICE 108
Holders and representatives
Holders
HUDSON INNOVATIONS, LLC
B D FORREST & COMPANY, INC.
Equitas Bio/Pharma Solutions, LLC
Representatives
HUDSON INNOVATIONS, LLC
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical and biopharmaceutical business plan development; business consultation services in the field of pharmaceutical and biopharmaceutical regulatory strategy; business consultation in the field of pharmaceutical and biopharmaceutical foreign market entry; business management services in the field of pharmaceutical and biopharmaceutical products and medical devices; business development and commercial administration of the licensing of pharmaceutical and biopharmaceutical products and medical devices; Providing advertisingmarketing and promotional services for pharmaceutical and biopharmaceutical products and medical devices; marketing plan development for pharmaceutical and biopharmaceutical products and medical devices; market research and business analyses and advice for pharmaceutical and biopharmaceutical products and medical devices
Class 42
Consulting servicespharmaceutical and biopharmaceutical product development; pharmaceutical and biopharmaceutical clinical development and product testing; research and development of pharmaceutical and biopharmaceutical products and medical devices
Class 45
Consulting in the field of pharmaceutical and biopharmaceutical regulations with regard to regulatory strategy
Publications
History of USPTO decisions and trademark events.
16 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/25/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/25/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/02/2022
ES8R
TEAS SECTION 8 RECEIVED
03/09/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/26/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/24/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/15/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/26/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/10/2016
PUBO
PUBLISHED FOR OPPOSITION
05/10/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/20/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2016
DOCK
ASSIGNED TO EXAMINER
03/29/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/19/2015
NWAP
NEW APPLICATION ENTERED
12/17/2015
Continuous trademark protection
Get notified about every new filing that threatens EQUITAS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.